Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Cytel to implement new development strategy for HBV vaccine

Dec. 6, 1996

Phase IIa trial on Isis antiinflammatory antisense compound completed

Dec. 5, 1996

Axcan-Schwarz joint venture to market URSO

Dec. 2, 1996

Chugai discloses erythromycins for gastrointestinal disorders

Nov. 27, 1996

OraVax and Pasteur-Merieux Connaught license H. pylori genome sequence

Nov. 26, 1996

Lilly claims 5-HT7 antagonist for GI indications

Nov. 26, 1996

New market introduction for proton pump inhibitor

Nov. 26, 1996

Neose reports promising phase I results for novel antiulcer drug

Nov. 25, 1996

PDL anti-HBV antibody enters phase II

Nov. 22, 1996

Novavax reports progress on products for H. pylori infection

Nov. 22, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...